Michael Parry
Overview
Explore the profile of Michael Parry including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
51
Citations
490
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Budacan A, Patel A, Babu P, Khalil H, Vaiyapuri S, Parry M, et al.
J Thorac Cardiovasc Surg
. 2024 Sep;
PMID: 39332520
Objectives: We aimed to analyze survival, predictors of outcome, and the long-term functional status of patients with a diagnosis of primary chest wall sarcoma who undergo chest wall resection and...
2.
Childs A, Gerrand C, Brennan B, Young R, Rankin K, Parry M, et al.
Cancers (Basel)
. 2024 Jul;
16(13).
PMID: 39001413
There has been little change to the standard treatment for osteosarcoma (OS) over the last 25 years and there is an unmet need to identify new biomarkers and novel therapeutic...
3.
Jeys L, Thorkildsen J, Kurisunkal V, Puri A, Ruggieri P, Houdek M, et al.
Bone Joint J
. 2024 May;
106-B(5):425-429.
PMID: 38689572
Chondrosarcoma is the second most common surgically treated primary bone sarcoma. Despite a large number of scientific papers in the literature, there is still significant controversy about diagnostics, treatment of...
4.
Verspoor F, Hannink G, Parry M, Jeys L, Stevenson J
Ann Surg Oncol
. 2023 Jul;
30(12):7882-7891.
PMID: 37505350
Background: The optimal surgical treatment for patients presenting with (impending and complete) pathological proximal femoral fractures is predicated on prognosis. Guidelines recommend a preoperative biopsy to exclude sarcomas, however no...
5.
Brookes M, Roundhill E, Jeys L, Parry M, Burchill S, Rankin K
Pediatr Blood Cancer
. 2023 Jan;
70(5):e30206.
PMID: 36651715
No abstract available.
6.
McCulloch R, Adlan A, Evans S, Parry M, Stevenson J, Jeys L
J Bone Jt Infect
. 2022 Dec;
6(9):425-432.
PMID: 36561206
: The gastrocnemius myofascial flap is used to manage soft-tissue defects over the anterior aspect of the knee in the context of a patient presenting with a sinus and periprosthetic...
7.
Brookes M, Roundhill E, Jeys L, Parry M, Burchill S, Rankin K
Pediatr Blood Cancer
. 2022 Sep;
69(12):e29959.
PMID: 36106829
Background: Ewing sarcoma (ES) is the second most common primary bone malignancy, with an urgent need for new treatments. ES is associated with high rates of progression and relapse, driven...
8.
McCulloch R, Adlan A, Jenkins N, Parry M, Stevenson J, Jeys L
J Bone Jt Infect
. 2022 Aug;
7(4):177-182.
PMID: 36032799
: this study compared the patient and microbiological profile of prosthetic joint infection (PJI) for patients treated with two-stage revision for knee arthroplasty with that of lower-limb endoprostheses for oncological...
9.
Maes D, AlAqeel M, Parry M, Botchu R, Sumathi V, Jeys L, et al.
Eur J Surg Oncol
. 2022 Aug;
49(2):345-352.
PMID: 36031468
Introduction: Haemorrhagic soft-tissue sarcomas (HSTS) are characterised by aggressive local growth and highly metastatic behaviour. We aimed to describe oncological outcomes and prognostic factors. Materials And Methods: Retrospective review including...
10.
Rajgor H, Dong H, Nandra R, Parry M, Stevenson J, Jeys L
Arch Orthop Trauma Surg
. 2022 Aug;
143(2):987-994.
PMID: 35980459
Background: Prosthetic joint infection (PJI) is associated with poor outcomes and catastrophic complications. The aim of this study was to present the outcomes of re-revision surgery for PJI of the...